Boudjelal; Mohamed

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boudjelal; Mohamed.The latest application filed is for "amplification method of a single stranded dna".

Company Profile

5.6.9

Boudjelal; Mohamed - Riyadh SA
Boudjelal; Mohamed - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof Grant 11,161,823 - Islam , et al. November 2, 2	2021-11-02
Methods for treating cancer using purine analogs by depleting intracellular ATP Grant 11,052,101 - Nehdi , et al. July 6, 2	2021-07-06
Amplification Method Of A Single Stranded Dna App 20210079458 - Nehdi; Atef ; et al.	2021-03-18
Methods For Treating Cancer Using Purine Analogs By Depleting Intracellular Atp App 20200306285 - NEHDI; Atef ; et al.	2020-10-01
Anticancer 1,3-dioxane-4,6-dione Derivatives And Method Of Combinatorial Synthesis Thereof App 20200290975 - ISLAM; Imadul ; et al.	2020-09-17
Method for treating leukemia Grant 10,639,382 - Boudjelal , et al.	2020-05-05
Method of treating leukemia based on gene expression of clock genes Grant 10,253,371 - Boudjelal , et al.	2019-04-09
Method Of Treating Leukemia App 20180296692 - BOUDJELAL; Mohamed ; et al.	2018-10-18
Method Of Treating Leukemia Based On Gene Expression Of Clock Genes App 20180057886 - BOUDJELAL; MOHAMED ; et al.	2018-03-01
Heterocyclic amide derivatives for the treatment of diabetes and other diseases App 20060241138 - Pfahl; Magnus ; et al.	2006-10-26
Heterocyclic amide derivatives for the treatment of diabetes and other diseases Grant 7,102,000 - Pfahl , et al. September 5, 2	2006-09-05
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases App 20060160796 - Pfahl; Magnus ; et al.	2006-07-20
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases Grant 7,071,218 - Pfahl , et al. July 4, 2	2006-07-04
Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases App 20050038098 - Tachdjian, Catherine ; et al.	2005-02-17
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases App 20030144329 - Pfahl, Magnus ; et al.	2003-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.